7 chapters across the catalog
NIH Data Deletion, COVID Sequences, Lab Leak Cover-up
FOIA documents reveal that the National Institute of Health deleted original COVID-19 genetic sequences from its database at the request of Chinese researchers. Critics argue this was part of an effort by officials like Dr. Anthony Fauci to suppress evidence supporting the lab leak theory in favor of the natural origin narrative.
Opioid Settlement, Moderna Patent, Lab Leak Hypothesis
A $26 billion settlement was reached with Johnson & Johnson and three drug distributors over the opioid epidemic, though no money will go directly to victims. In COVID-19 news, Moderna CEO Stéphane Bancel was questioned about a genetic sequence in the virus that matches a 2016 Moderna patent. Bancel acknowledged the possibility of a lab leak, a significant shift from previous dismissals of the theory.
Moderna Patent Sequence and Alien Antidote Theory
A genetic sequence found in SARS-CoV-2 reportedly matches a 2017 patent held by Moderna. This discovery fuels theories that the virus was engineered, with some speculating that the Omicron variant may have been a deliberately released "antidote" to end the pandemic.
Genetic Sequencing Assays, UK Variant-of-Concern Briefing Data
Health departments utilize monthly genetic sampling assays rather than testing every individual sample to determine variant dominance, with recent California data showing Delta at 90% prevalence. In the United Kingdom, a variant-of-concern briefing indicates a narrow gap in mortality between vaccinated and unvaccinated individuals, with 50 deaths recorded for the vaccinated versus 44 for the unvaccinated in a specific sample.
Coronavirus Mutations, Washington Post Strain Study
A study reported by the Washington Post suggests that the D614G mutation of the coronavirus may be more contagious than previous strains. The research, conducted at Houston Methodist Hospital, analyzed 5,000 genetic sequences. However, the study's reliance on backlogged data from the summer wave in Texas has led to questions about its conclusions.
South Korea, COVID-19 Testing Strategy and Transparency
South Korea's low fatality rate is attributed to a highly wired healthcare system and the rapid development of testing reagents following the release of the virus's genetic sequence in January. The country has processed over 250,000 tests, focusing on early detection and transparency to maintain public trust.
23andMe DNA Testing and Genetic Sensitivities
A CNET segment on 23andMe DNA testing is mocked for its focus on trivial genetic traits, such as a sensitivity to body odor or a preference for meat over sugar. The hosts propose a satirical "No Agenda DNA Sequencing" service that provides humorous, randomized results.
